Psychiatric Disorders Common in Pediatric MS, Demyelinating Diseases
Notably, patients who had documented psychotic and psychiatric disorders were more likely to be diagnosed with a demyelinating disease.
ECTRIMS 2016 Coverage
Dimethyl-Fumarate May Maintain NEDA After Natalizumab Discontinuation
Over 90% of participants achieved NEDA-3 after being transitioned to dimethyl-fumarate from natalizumab.
Smoking May Accelerate White Matter Damage in Progressive MS
The relationship between microstructural damage in NAWM and clinical measures was less clear, suggesting another mechanism.
Enriching Experiences May Protect Against Cognitive Decline in MS
Researchers examined whether the cognitive reserve hypothesis could predict cognitive decline, gray matter volume changes, and white matter volume changes in MS patients.
High-Fat Diets May Increase Relapse Risk in Pediatric MS
High-fat diets may increase the risk of relapse in children with MS, while high-vegetable diets may be protective.
Genetic Risk Score Identifies Pediatric Patients With Greater MS Relapse Risk
Six polymorphisms were found to be strongly associated with vitamin D levels in the patient population.
Axon Diameter May Help Detect, Track Multiple Sclerosis
Axon diameter dynamics may serve as a novel biomarker for MS disease course.
Early Tx Exposure May Prevent Progression in Pediatric Clinically Isolated Syndrome
Patients at the greatest risk of disability progression were older than 12 years, and had minimal exposure to DMTs.
BMI, Lipid Levels Influence Multiple Sclerosis Disease Course
Higher BMI and lipid levels were associated with greater risk of relapse and disability progression.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in ECTRIMS 2016 Coverage
Loading... 
Loading...